Skip to content
Recall Observatory FDA recall evidence

Drug product

LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL

D-0910-2016

March 31, 2016

Class II

Product summary

Firm
Invisiblu International LLC
Event
Event 73698
Status
Ongoing
Classification
Class II
Quantity
3,319 bottles
Official record key
drug-enforcement:D-0910-2016

Official wording

Reason: Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033

Code information: Lot # 21511166, Exp 11/18

Distribution pattern: Nationwide and Brazil.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033